MARKET

HURA

HURA

TuHURA Biosciences
NASDAQ
4.580
+0.030
+0.66%
Closed 16:00 02/13 EST
OPEN
4.610
PREV CLOSE
4.550
HIGH
4.750
LOW
4.510
VOLUME
137.90K
TURNOVER
--
52 WEEK HIGH
14.60
52 WEEK LOW
2.835
MARKET CAP
193.66M
P/E (TTM)
-0.3605
1D
5D
1M
3M
1Y
5Y
1D
TuHURA Biosciences Inc <HURA.OQ> expected to post a loss of 13 cents a share - Earnings Preview
Reuters · 3d ago
Weekly Report: what happened at HURA last week (0203-0207)?
Weekly Report · 3d ago
Weekly Report: what happened at HURA last week (0127-0131)?
Weekly Report · 02/03 10:24
Weekly Report: what happened at HURA last week (0120-0124)?
Weekly Report · 01/27 10:25
Weekly Report: what happened at HURA last week (0113-0117)?
Weekly Report · 01/20 10:20
Weekly Report: what happened at HURA last week (0106-0110)?
Weekly Report · 01/13 10:21
Weekly Report: what happened at HURA last week (1230-0103)?
Weekly Report · 01/06 10:26
Weekly Report: what happened at HURA last week (1223-1227)?
Weekly Report · 12/30/2024 10:22
More
About HURA
TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first line treatment for advanced Merkel cell carcinoma. In addition, the Company is leveraging its Delta receptor technology to develop novel bi-functional antibody drug conjugates (ADCs), targeting myeloid derived suppressor cells to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. Its IFx platform technology utilizes a proprietary plasmid DNA (pDNA) or messenger RNA (mRNA).

Webull offers TuHURA Biosciences Inc stock information, including NASDAQ: HURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HURA stock methods without spending real money on the virtual paper trading platform.